<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Phospho-Proteomics Method Optimization and Application to Stimulated Jurkat Cells - Health AI Hub</title>
    <meta name="description" content="This study optimized phospho-proteomics methods for limited input and formalin-fixed cells, demonstrating that phospho-bulk titration improves phospho-peptide i">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Phospho-Proteomics Method Optimization and Application to Stimulated Jurkat Cells</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.02932v1" target="_blank">2511.02932v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-04
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Teresia Ndungu, Jana Zecha, Lisa Cazares, Sonja Hess
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> q-bio.QM, q-bio.GN
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.90 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.02932v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="http://arxiv.org/pdf/2511.02932v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This study optimized phospho-proteomics methods for limited input and formalin-fixed cells, demonstrating that phospho-bulk titration improves phospho-peptide identification from low input. It established an efficient decrosslinking protocol for fixed samples and successfully applied these optimized methods to identify key phospho-sites in stimulated Jurkat cells relevant to T-cell activation.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Optimized phospho-proteomics enables sensitive analysis of protein phosphorylation, crucial for identifying disease biomarkers, understanding pathology, and developing therapeutic strategies, particularly in cancer and immunology, even with scarce or historically fixed clinical samples.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>Not applicable. The paper focuses on wet-lab method optimization for phospho-proteomics and does not describe any AI applications to health.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Phospho-proteomics is crucial for understanding post-translational modification (PTM) dysregulation in diseases like cancer, but often challenged by limited sample input in clinical settings.</li>
                    
                    <li>Phospho-bulk titration was found to be a more effective strategy for low-input phospho-proteomics, identifying more phospho-peptides due to reduced sample loss compared to preparing low-input starting material directly.</li>
                    
                    <li>An optimal decrosslinking protocol for formalin-fixed cells (FFC) was identified: boiling in 0.05M Tris pH 7.6 with 5% SDS for 60 minutes, which yielded the highest number of phospho-peptides.</li>
                    
                    <li>The optimized decrosslinking protocol addresses a significant challenge in utilizing valuable formalin-fixed archival clinical samples for phospho-proteomic analysis.</li>
                    
                    <li>The study successfully applied the optimized methods, including Evotips Pure and phospho-bulk titration, to treated Jurkat cells.</li>
                    
                    <li>Application to stimulated Jurkat cells led to the identification of 7 specific phospho-sites directly involved in T-cell stimulation pathways.</li>
                    
                    <li>The research provides robust methodological advancements for sensitive and comprehensive phospho-proteomic analysis of challenging clinical and research samples.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study involved evaluating phospho-bulk titration against direct low-input material preparation, optimizing various lysis buffers and boiling times for efficient decrosslinking of formalin-fixed cells, and applying Evotips Pure in conjunction with phospho-bulk titration for mass spectrometry-based phospho-peptide identification in stimulated Jurkat cells.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>Phospho-bulk titration significantly increased phospho-peptide identification compared to direct low-input starting material due to reduced sample loss. Optimal decrosslinking of formalin-fixed cells for phospho-proteomics was achieved by boiling in 0.05M Tris pH 7.6 with 5% SDS for 60 minutes. The optimized methods successfully identified 7 specific phospho-sites involved in T-cell stimulation in Jurkat cells.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>These methodological advancements enable more comprehensive and sensitive phospho-proteomic analysis of limited and formalin-fixed clinical samples, facilitating the discovery of phosphorylation-based biomarkers in diseases like cancer, improving understanding of immune responses, and accelerating the development of targeted therapies.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>Not explicitly mentioned in the abstract, but typical limitations might include validation across a wider range of tissue types or disease states, and comprehensive assessment of quantitative reproducibility across different sample matrices.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Not explicitly mentioned in the abstract. However, logical next steps would involve applying these optimized methods to diverse patient cohorts and various disease models to identify novel disease-specific phosphorylation signatures and validate them as biomarkers or therapeutic targets in clinical settings.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Oncology</span>
                    
                    <span class="tag">Immunology</span>
                    
                    <span class="tag">Clinical Proteomics</span>
                    
                    <span class="tag">Pathology</span>
                    
                    <span class="tag">Biomarker Discovery</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Phospho-proteomics</span>
                    
                    <span class="tag tag-keyword">Post-translational modifications</span>
                    
                    <span class="tag tag-keyword">Low input proteomics</span>
                    
                    <span class="tag tag-keyword">Formalin-fixed cells</span>
                    
                    <span class="tag tag-keyword">Decrosslinking</span>
                    
                    <span class="tag tag-keyword">Jurkat cells</span>
                    
                    <span class="tag tag-keyword">T-cell stimulation</span>
                    
                    <span class="tag tag-keyword">Mass spectrometry</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">In clinical proteomics, available input is often limited. In addition,
phospho-proteomics is of particular interest since the dysregulation of these
post-translational modifications (PTMs) has been implicated in various diseases
such as cancer. We therefore assessed the feasibility of low input
phospho-proteomics via phospho-bulk titration and low-input starting material.
We found that there was identification of more phospho-peptides through
phospho-bulk titration because of sample loss during preparation of low input
starting material. Additionally, we explored various lysis buffers and boiling
times for efficiency of decrosslinking formalin-fixed cells since cells and
tissues are often fixed for preservation and sorting via FACS. We found that
boiling in 0.05M Tris pH 7.6 with 5% SDS for 60 min yielded the highest number
of phospho-peptides. Lastly, we applied Evotips Pure and phospho-bulk titration
to treated Jurkat cells and identified 7 phospho-sites involved in T-cell
stimulation.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>14 pages, 4 figures</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>